Quality of life in cancer: Definition, purpose, and method of measurement

Cancer Investigation

Volumn 11, Issue 3, 1993, Pages 327-336

  Cella, David F ^a   Tulsky, David S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; HUMAN; QUALITY OF LIFE; SHORT SURVEY;

ADULT; AGE FACTORS; CHILD; CHILD DEVELOPMENT; HEALTH STATUS; HUMAN; NEOPLASMS; PLAY AND PLAYTHINGS; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 0027217317     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909309024860     Document Type: Article

References (72)

1. Quality of life assessment: Evolution of the concept
2. Measuring quality of life today: Methodological aspects
3. Quality of life during and after cancer treatment
4. Measuring and analysing quality of life in cancer clinical trials: A review
5. Quality-of-life measurement
6. Measuring quality of life: Risks and benefits
7. The evolution of quality of life evaluations in cancer therapy
8. Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study
9. The Medical Outcomes Study: An application of methods for monitoring the results of medical care
10. The functioning and well-being of depressed patients
11. Psychosocial research in cancer: The Cancer and Leukemia Group B experience
12. Quality of life end points in cancer clinical trials: Review and recommendations
13. Cancer Inventory of Problem Situations: An instrument for assessing cancer patients' rehabilitation needs
14. Sickness Impact Profile: Validation of a health status measure
15. The Sickness Impact Profile: Development and final revision of a health status measure
16. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast
17. Improving the quality of life during chemotherapy for advanced breast cancer
18. Quality of life assessment of patients in extremity sarcoma trials
19. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer
20. A modular approach to quality-of-life assessment in cancer clinical trials
21. The MOS Short-tornl General Health Survey: Reliability and validity in a patient population
22. Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation
23. Quality of life index for patients with cancer
24. Evaluation of quality of life in patients receiving treatment for advanced breast cancer
25. The development of a method for assessing the quality of life of cancer patients
26. The clinical evaluation of chein-otherapeutic agents in cancer
27. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphor-aniide
28. Assessment of quality of life by the Functional Living Index-Cancer (FLIC) is superior to performance status for prediction of survival in patients with lung cancer
29. The Anamnestic Comparative Self Assessnient for measuring the subjective quality of life of cancer patients
30. Assessment of the quality of life of patients with advanced cancer
31. Methodological issues in psychosocial oncology with special reference to clinical trials
32. Advances in the measurement of functional status: Construction of aggregate indexes
33. Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination chemotherapy
34. Mood states of patients after the diagnosis of cancer
35. Measuring quality of life in cancer patients
36. Measuring the quality of life of cancer patients: A concise QL-Index for use by physicians
37. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky Performance Status and the Functional Living Index-Cancer
38. Practical probleinr in conducting cancer-related psycho Social research
39. Practical concerns and pittalls in measurement methodology
40. Classifying function for health outconie and quality of life evaluation: Self-versus interviewer modes
41. A pilot study of the Functional Living Index-Cancer (FLIC) scale for the asscssinent of quality of life for metastatic lung cancer patients
42. The measurement of performance in childhood cancer patients
43. Asscssment of quality of life among pediatric patients with canccr
44. Play performance scale as an index of quality of life of children with cancer
45. Pediatrics: Assessing quality of life
46. A Methodology for a Utility-Based Health Status Index for Ontario Children
47. Measuring components of children's health status
48. Lives in a balance: Perceived family functioning and the psycho Social adjustment of adolescent cancer survivors
49. Studies of illness in the aged. The Index of ADL
50. Health as an investment
51. Cost-effectivene's wing a health status index: Analysis of the New York State PKU weening program
52. Cost-effective priorities for cancer prevention
53. Health-related quality of life measurement for evaluation research and policy analysis
54. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer
55. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer
56. Quality of life in advanced cancer: Three new disease-specific measures
57. The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure
58. Quality of life in stage II breast cancer: An instrument for clinical trials
59. Performance parameters in head and neck patients
60. Linear analogue self-assessment of voice quality in laryngeal cancer
61. Quality of life assessment: An independent prognostic variable for survival in lung cancer